Business / Finance

RSS

Masimo announces acquisition of Spire Semiconductor

Masimo, the inventor of Masimo Rainbow Pulse CO-Oximetry, Masimo Rainbow Acoustic Monitoring, and Masimo SET Measure-Through Motion and Low Perfusion pulse oximetry, today announced it has acquired substantially all of the assets of Spire Semiconductor, LLC, maker of advanced light emitting diode and other advanced component-level technologies.

12 Mar 2012

HemaQuest closes $13 million extension of Series B financing

HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.

12 Mar 2012

ACRONET joins Medidata Partner Program

As clinical trial activity in the Asia Pacific region continues to expand and contract research organizations (CRO) increasingly provide sponsors with a range of strategic services and support, ACRONET joined the Medidata Partner Program to enhance its technology offerings across the clinical development process.

12 Mar 2012

OPKO Health, Scripps Research partner to commercialize Parkinson's disease compound, SR 3306

The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.

12 Mar 2012

Medisafe 1 Technologies, Natural Dream Laboratories enter distribution agreement

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has signed a distribution agreement with Natural Dream Laboratories Company Ltd for Medisafe 1 to carry a wide range of health related products in the Natural Dream laboratories Company product line.

12 Mar 2012

LensAR closes $24 million private financing

LensAR Inc., a developer of the next generation of laser systems for cataract surgery, announced the closing of a $24 million private financing which included investments from Aisling Capital and Florida Growth Fund (FGF).

12 Mar 2012

AB SCIEX announces commercial expansion in Brazil

AB SCIEX, a global leader in life science analytical technologies, today announced its expansion of commercial operations in Brazil to support the Brazilian scientific community's increasing use of mass spectrometry for food safety testing, environmental analysis, academic research, drug development, forensic toxicology and clinical research.

12 Mar 2012

Zynex announces acquisition of NeuroDyne Medical

Zynex, Inc., a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced the acquisition of substantially all the assets of NeuroDyne Medical, Corp., through its subsidiary Zynex NeuroDiagnostics, Inc., with an effective date of March 9, 2012.

12 Mar 2012

Antares Pharma fourth quarter revenues increase 65% to $5.4 million

Antares Pharma, Inc. today reported financial and operating results for the fourth quarter and full year ended December 31, 2011 and outlined key objectives and milestones for 2012.

12 Mar 2012

ShangPharma fourth quarter net revenues increase 19.0% to $30.5 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.

12 Mar 2012

Asahi Kasei to acquire ZOLL

Asahi Kasei Corporation, and ZOLL Medical Corporation today jointly announced that Asahi Kasei, Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion.

12 Mar 2012

AMGA honors Abbott with Distinguished Corporate Partner Award

The American Medical Group Association (AMGA) announced today that it will present the AMGA Distinguished Corporate Partner Award on March 10 to Abbott Laboratories at its 2012 Annual Conference, March 8-10 at the Manchester Grand Hyatt.

12 Mar 2012

4th quarter hospital revenues increase

Spending at hospitals surged in the fourth quarter, government data showed on Thursday, suggesting economic growth during that period could be revised significantly higher.

10 Mar 2012

Emergent BioSolutions fourth quarter total revenues increase to $107.9M

Emergent BioSolutions Inc. announced today its financial results for the fourth quarter and full year ended December 31, 2011.

9 Mar 2012

3SBio fourth quarter total net revenues increase 38.2% to RMB139.9M

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced its unaudited financial results for the fourth quarter and full year ended December 31, 2011.

9 Mar 2012

Maxygen reports net loss of $2.2 million for fourth quarter 2011

Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.

9 Mar 2012

AMN consolidated revenue increases 32% to $887M for full year 2011

AMN Healthcare Services, Inc., the nation's innovator in healthcare workforce solutions, today announced financial results for the full year and fourth quarter 2011. The results were at the upper end of management's expectations, the Company said.

9 Mar 2012

Boston Scientific exercises option to acquire Cameron Health

Boston Scientific Corporation announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San Clemente, California.

9 Mar 2012

GenMark Diagnostics fourth quarter revenues increase to $2.0M

GenMark Diagnostics, Inc. today reported preliminary financial results for the fourth quarter and fiscal year ended December 31, 2011. The Company will release its full financial statements and related disclosures along with its Form 10-K filing for the period ending December 31, 2011 upon completion of its independent audit, which includes the Company's first Sarbanes-Oxley audit of internal controls, by March 15, 2012.

9 Mar 2012

PharmAthene revenue increases to $24.3M for year ended December 31, 2011

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the year ended December 31, 2011.

9 Mar 2012